Recruiting Duchenne Muscular Dystrophy Studies in New York
About Duchenne Muscular Dystrophy Clinical Trials in New York
Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.
There are currently 1 duchenne muscular dystrophy clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 50 participants. Research is being sponsored by Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Duchenne Muscular Dystrophy Clinical Trials in New York — FAQ
Are there duchenne muscular dystrophy clinical trials in New York?
Yes, there are 1 duchenne muscular dystrophy clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What duchenne muscular dystrophy treatments are being tested?
The 1 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.
Data updated March 2, 2026 from ClinicalTrials.gov